Literature DB >> 21317585

Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community.

Keren Middelkoop1, Linda-Gail Bekker, Landon Myer, Leigh F Johnson, Matthew Kloos, Carl Morrow, Robin Wood.   

Abstract

BACKGROUND: Antiretroviral therapy (ART) has been proposed as an intervention for reducing tuberculosis (TB) burdens in areas with high HIV prevalence. However, little data is available on the impact of ART on population-level TB.
METHODS: Trends in adult TB case fatality and notifications were assessed before and during increasing ART coverage in a well-defined periurban community, from 1997 to 2008. Mean changes in TB rates were measured using linear autoregression models. ART coverage increased from 1% in 2003 to 5%, 13%, and 21% of HIV-infected population in 2004, 2005, and 2008, respectively.
RESULTS: From 1997 to end of 2004 TB notification rates increased by an average of 187 cases/100,000/year (P < 0.001), reaching a peak of 2536/100,000 in 2005. From 2005 to 2008, TB notification rates declined by approximately 202 cases/100,000/year (P < 0.001). TB rates were initially stable in HIV-uninfected individuals, but declined moderately from 2005. TB rates declined in HIV-infected adults from 6513/100,000 in 2005 to 4741/100,000 in 2008. The predominant decline in TB notifications occurred among HIV-infected patients receiving ART (1156 cases/100,000/year) and was less marked in those not receiving ART (416 cases/100,000/year). Similarly, TB case fatality was constant for HIV-uninfected individuals, but declined in HIV-infected individuals from 23% in 2002 to 8% in 2008 (P = 0.01).
CONCLUSIONS: In this community heavily affected by both HIV and TB epidemics, rapid and high ART coverage was associated with significant reductions in TB notifications and TB-associated case fatality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317585      PMCID: PMC3801097          DOI: 10.1097/QAI.0b013e31820413b3

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  18 in total

1.  CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment.

Authors:  Charles B Holmes; Robin Wood; Motasim Badri; Sophia Zilber; Bingxia Wang; Gary Maartens; Hui Zheng; Zhigang Lu; Kenneth A Freedberg; Elena Losina
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-01       Impact factor: 3.731

2.  Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.

Authors:  Enrico Girardi; Caroline A Sabin; Antonella d'Arminio Monforte; Bob Hogg; Andrew N Phillips; M John Gill; Francois Dabis; Peter Reiss; Ole Kirk; Enos Bernasconi; Sophie Grabar; Amy Justice; Schlomo Staszewski; Gerd Fätkenheuer; Jonathan A C Sterne
Journal:  Clin Infect Dis       Date:  2005-11-11       Impact factor: 9.079

3.  Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.

Authors:  Stephen D Lawn; Motasim Badri; Robin Wood
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

4.  Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.

Authors:  Stephen D Lawn; Landon Myer; Catherine Orrell; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

Review 5.  Natural history and spectrum of disease in adults with HIV/AIDS in Africa.

Authors:  A D Grant; G Djomand; K M De Cock
Journal:  AIDS       Date:  1997       Impact factor: 4.177

6.  Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township.

Authors:  Keren Middelkoop; Linda-Gail Bekker; Landon Myer; Andrew Whitelaw; Alison Grant; Gilla Kaplan; James McIntyre; Robin Wood
Journal:  Am J Respir Crit Care Med       Date:  2010-06-17       Impact factor: 21.405

Review 7.  Tuberculosis and HIV infection in sub-Saharan Africa.

Authors:  K M De Cock; B Soro; I M Coulibaly; S B Lucas
Journal:  JAMA       Date:  1992 Sep 23-30       Impact factor: 56.272

8.  Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions.

Authors:  Stephen D Lawn; Linda-Gail Bekker; Keren Middelkoop; Landon Myer; Robin Wood
Journal:  Clin Infect Dis       Date:  2006-02-16       Impact factor: 9.079

9.  Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

Authors:  Brian G Williams; Christopher Dye
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

10.  Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

Authors:  Motasim Badri; Douglas Wilson; Robin Wood
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

View more
  34 in total

1.  High mortality in tuberculosis patients despite HIV interventions in Swaziland.

Authors:  G Mchunu; J van Griensven; S G Hinderaker; W Kizito; W Sikhondze; M Manzi; T Dlamini; A D Harries
Journal:  Public Health Action       Date:  2016-06-21

2.  Scale-up of ART in Malawi has reduced case notification rates in HIV-positive and HIV-negative tuberculosis.

Authors:  H Kanyerere; B Girma; J Mpunga; K Tayler-Smith; A D Harries; A Jahn; F M Chimbwandira
Journal:  Public Health Action       Date:  2016-12-21

3.  Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community.

Authors:  Keren Middelkoop; Linda-Gail Bekker; Barun Mathema; Landon Myer; Elena Shashkina; Andrew Whitelaw; Natalia Kurepina; Gilla Kaplan; Barry Kreiswirth; Robin Wood
Journal:  Int J Epidemiol       Date:  2014-03-07       Impact factor: 7.196

4.  Decline in national tuberculosis notifications with national scale-up of antiretroviral therapy in Malawi.

Authors:  H Kanyerere; A Mganga; A D Harries; K Tayler-Smith; A Jahn; F M Chimbwandira; J Mpunga
Journal:  Public Health Action       Date:  2014-06-21

5.  Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment.

Authors:  K Middelkoop; L-G Bekker; E Shashkina; B Kreiswirth; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2012-09-14       Impact factor: 2.373

6.  Adaptive pair-matching in randomized trials with unbiased and efficient effect estimation.

Authors:  Laura B Balzer; Maya L Petersen; Mark J van der Laan
Journal:  Stat Med       Date:  2014-11-25       Impact factor: 2.373

7.  Transmission of tuberculosis in a South African community with a high prevalence of HIV infection.

Authors:  Keren Middelkoop; Barun Mathema; Landon Myer; Elena Shashkina; Andrew Whitelaw; Gilla Kaplan; Barry Kreiswirth; Robin Wood; Linda-Gail Bekker
Journal:  J Infect Dis       Date:  2014-07-22       Impact factor: 5.226

8.  Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.

Authors:  S Gupta; T Abimbola; A Date; A B Suthar; R Bennett; N Sangrujee; R Granich
Journal:  Int J Tuberc Lung Dis       Date:  2014-10       Impact factor: 2.373

Review 9.  HIV and tuberculosis--science and implementation to turn the tide and reduce deaths.

Authors:  Anthony D Harries; Stephen D Lawn; Haileyesus Getahun; Rony Zachariah; Diane V Havlir
Journal:  J Int AIDS Soc       Date:  2012       Impact factor: 5.396

Review 10.  HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention.

Authors:  David P Wilson
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.